Tiratricol-Containing Products Not Dietary Supplements - U.S. Judge
This article was originally published in The Tan Sheet
Executive Summary
Tiratricol cannot be marketed as a dietary supplement because it has been the subject of an investigational new drug application since 1990, a Cape Girardeau, Mo. federal judge has ruled in an FDA enforcement action against Syntrax Innovations.
You may also be interested in...
Syntrax LipoKinetix Liver AERs Necessitate Product Removal – FDA
LipoKinetix should be withdrawn from the market due to reports linking the weight-loss supplement to "at least six" cases of serious liver injury, FDA states in a 1Nov. 19 letter to Chaufee, Mo.-based Syntrax Innovations
Tiratricol
ATF Fitness recalling BioPharm T-Cuts supplement containing ingredient deemed to be a "potent thyroid hormone" that may cause heart attacks, strokes. Oakmont, Penn.-based ATF distributed 90-count bottles of T-Cuts (made by BioPharm) nationwide through mail order, health food stores and gyms. Approximately 400 bottles are affected by recall. FDA actions against tiratricol products culminated in recent decision by Missouri federal judge that ingredient cannot be marketed as supplement because it has been the subject of an IND since 1990 (1"The Tan Sheet" March 12, p. 10)
Triax Weight Loss Supplement Distribution Halted At FDA's Request
The Missouri Department of Health has barred dietary supplement distributor Syntrax Innovations from selling its on-hand supply of a weight loss nutritional supplement due to FDA concerns the product is an unapproved new drug.